The Stochastic Oscillator for ESTA moved into oversold territory on November 03, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ESTA's RSI Indicator exited the oversold zone, 23 of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on October 22, 2026. You may want to consider a long position or call options on ESTA as a result. In 82 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for ESTA just turned positive on October 20, 2026. Looking at past instances where ESTA's MACD turned positive, the stock continued to rise in 46 of 53 cases over the following month. The odds of a continued upward trend are 87%.
Following a +4.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where ESTA advanced for three days, in 239 of 307 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
ESTA moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for ESTA moved below the 200-day moving average on October 08, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESTA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
ESTA broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ESTA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 13 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ESTA's P/B Ratio (84.687) is very high in comparison to the industry average of (4.170). P/E Ratio (-48.346) is within average values for comparable stocks, (1.500). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (8.749) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. ESTA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ESTA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The Moving Average Convergence Divergence (MACD) for MLSS turned positive on October 29, 2026. Looking at past instances where MLSS's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MLSS's RSI Oscillator exited the oversold zone, 18 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 69 cases where MLSS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +3.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where MLSS advanced for three days, in 179 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
MLSS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MLSS as a result. In 97 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MLSS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for MLSS entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. MLSS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.934) is normal, around the industry mean (4.946). P/E Ratio (-6.078) is within average values for comparable stocks, (38.797). MLSS's Projected Growth (PEG Ratio) (37.320) is very high in comparison to the industry average of (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.601) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MLSS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
ESTA | MLSS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 21 | 57 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 13 Undervalued | 98 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 62 | 76 | |
P/E GROWTH RATING 1..100 | 14 | 21 | |
SEASONALITY SCORE 1..100 | 50 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ESTA's Valuation (13) in the Medical Specialties industry is significantly better than the same rating for MLSS (98). This means that ESTA’s stock grew significantly faster than MLSS’s over the last 12 months.
ESTA's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as MLSS (100). This means that ESTA’s stock grew similarly to MLSS’s over the last 12 months.
ESTA's SMR Rating (99) in the Medical Specialties industry is in the same range as MLSS (99). This means that ESTA’s stock grew similarly to MLSS’s over the last 12 months.
ESTA's Price Growth Rating (62) in the Medical Specialties industry is in the same range as MLSS (76). This means that ESTA’s stock grew similarly to MLSS’s over the last 12 months.
ESTA's P/E Growth Rating (14) in the Medical Specialties industry is in the same range as MLSS (21). This means that ESTA’s stock grew similarly to MLSS’s over the last 12 months.
| ESTA | MLSS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 82% | 1 day ago 72% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 85% | 2 days ago 90% |
| MACD ODDS (%) | 1 day ago 87% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 79% | 1 day ago 80% |
| TrendMonth ODDS (%) | 1 day ago 79% | 1 day ago 90% |
| Advances ODDS (%) | 7 days ago 78% | 15 days ago 78% |
| Declines ODDS (%) | 2 days ago 77% | 5 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 83% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 80% | 1 day ago 90% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ESTA’s FA Score shows that 2 FA rating(s) are green while MLSS’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ESTA’s TA Score shows that 5 TA indicator(s) are bullish while MLSS’s TA Score has 5 bullish TA indicator(s).
ESTA (@Medical/Nursing Services) experienced а -8.29% price change this week, while MLSS (@Pharmaceuticals: Other) price change was +1.30% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.01%. For the same industry, the average monthly price growth was -7.51%, and the average quarterly price growth was -8.84%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.70%. For the same industry, the average monthly price growth was -1.70%, and the average quarterly price growth was +10.08%.
ESTA is expected to report earnings on Mar 02, 2027.
MLSS is expected to report earnings on Nov 12, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-0.70% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, ESTA has been loosely correlated with NPCE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ESTA jumps, then NPCE could also see price increases.
| Ticker / NAME | Correlation To ESTA | 1D Price Change % | ||
|---|---|---|---|---|
| ESTA | 100% | +0.54% | ||
| NPCE - ESTA | 46% Loosely correlated | -0.24% | ||
| RDNT - ESTA | 41% Loosely correlated | +0.11% | ||
| NVST - ESTA | 39% Loosely correlated | +0.24% | ||
| NTRA - ESTA | 37% Loosely correlated | +2.56% | ||
| ISRG - ESTA | 36% Loosely correlated | +0.89% | ||
More | ||||